Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The dosage will vary depending on the specific product and individual health needs
Vanommeslaeghe, K
Kolatorova L, Vitku J, Suchopar J, Hill M, Parizek A
Related BPC-157 Research Compounds Researchers working with the BPC-157 TB-500 blend may also be interested in these related compounds from our catalogue: BPC-157 5mg standalone BPC-157 for isolated single-compound research protocols BPC-157 10mg higher dosage standalone vial for extended research cycles BPC-157 15mg maximum standalone dosage for high-concentration laboratory studies BPC-157 + TB-500 20mg Blend double-strength version of this formulation for extended protocols BPC-157 + TB-500 + GHK-Cu 30mg Glow Blend triple-compound blend adding copper peptide for extracellular matrix research All compounds are independently tested by Janoshik Analytical and supplied with batch-specific COA documentation
Peptide therapies may not be FDA-approved for all uses and may not be appropriate for every patient
In mice, supplementation with auraptene (P45-60) and umbelliprennin in males (for 7 days between P51-60) [62] prevented POS-induced anxiety-like behavior in OFT and EPM at two months of age [63] and in the EPM immediately after treatment [62]
US$ 21.58
US$ 27.05
US$ 27.01
US$ 26.69
US$ 27.74
